There are 807 resources available
276MO - Superior single agent effectiveness with plinabulin (Plin) versus (vs) placebo (Plac) for docetaxel (Doc)-induced neutropenia (DIN) prevention in non-small cell lung cancer (NSCLC) patients (pts)
Presenter: Douglas Blayney
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
YO22 - Durable complete response to Alectinib in a second line setting in metastatic ALK+ve NSCLC patient with poor PS with initial NG tube administration
Presenter: Nitin Murthy
Session: Unusual challenges in clinical oncology: YO case discussions
Resources:
Abstract
Slides
Webcast
277MO - Filgrastim versus pegfilgrastim as primary prevention for reduction of chemotherapy induced febrile neutropenia in Nepal
Presenter: Rajeev Sharma
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
Invited Discussant 275MO, 276MO and 277MO
Presenter: Florian Scotté
Session: Mini Oral session: Supportive and palliative care
Resources:
Slides
Webcast
Invited Discussant YO21 and YO22
Presenter: Teresa Amaral
Session: Unusual challenges in clinical oncology: YO case discussions
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Paolo Bossi
Session: Mini Oral session: Supportive and palliative care
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Teresa Amaral
Session: Unusual challenges in clinical oncology: YO case discussions
Resources:
Webcast
YO6 - Challenging case study of a transgender prostate cancer patient
Presenter: Khobe Chandran
Session: Unusual challenges in clinical oncology: YO case discussions
Resources:
Abstract
Slides
Webcast
278MO - Adherence optimisation, benefits, and limitations of oral anti-cancer therapy: A systematic review of patient preferences
Presenter: Amy Davies
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
YO14 - Parotid Gland Salivary Duct Adenocarcinoma: New targets for new times
Presenter: Clara Garcia Gonzalez
Session: Unusual challenges in clinical oncology: YO case discussions
Resources:
Abstract
Slides
Webcast